Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.95%
#2 clBTC clBTC +12.15%
#3 OpenEden OpenEden +11.48%
#4 BasedHype BasedHype +11.14%
#5 Wrapped Ether (Mantle Bridge) Wrapped Ether (Mantle Bridge) +8.73%
#6 Not in Employment, Education, or Training Not in Employment, Education, or Training +8.41%
#7 Mantle Staked Ether Mantle Staked Ether +8.34%
#8 Mantle Restaked ETH Mantle Restaked ETH +8.01%
#9 MarsCoin MarsCoin +6.65%
#10 EfficientFrontier EfficientFrontier +4.93%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Settings
Language
ENGLISH
Currency
USD
Theme
Nexera Technologies Ltd Nexera Technologies Ltd

Nexera Technologies Ltd

NEXR
Rank in Stocks #40230
Nexera Technologies Ltd. operates as an e-commerce enterprise primarily focused... Nexera Technologies Ltd. operates as an e-commerce enterprise primarily focused on consumer goods. The company serves as a holding entity for three distinct online retail subsidiaries—Smart Repair Pro, Purex Corp. (known as Purex), and Top Rank Ltd (referred to as Top Rank). These subsidiaries manage web stores that market a diverse array of consumer products exclusively through the Amazon online marketplace, leveraging Amazon's Fulfillment by Amazon (FBA) service for logistics. Viki Hakmon established Nexera Technologies on March 7, 2021, and its headquarters are situated in Bnei Braq, Israel.
Share Price
$3.39
Last synced: 2026-07-31
Market Cap
$201.27K
Change (1 day)
778.24%
Change (1 year)
-
Country
IL
Trade Nexera Technologies Ltd (NEXR)

Category

Healthcare
Revenue for Nexera Technologies Ltd (NEXR)
Revenue in Aug 2026 TTM: 0
According to Nexera Technologies Ltd latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Nexera Technologies Ltd from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE